Chris Cooley
Stock Analyst at Stephens & Co.
(1.94)
# 1,620
Out of 4,479 analysts
39
Total ratings
70.27%
Success rate
47.39%
Average return
Main Sectors:
Top Industries:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintains: Overweight | $39 → $42 | $45.07 | -6.81% | 2 | May 11, 2023 | |
| ALGN Align Technology | Maintains: Overweight | $500 → $375 | $239.74 | +56.42% | 6 | Jul 28, 2022 | |
| COO The Cooper Companies | Maintains: Overweight | $125 → $115 | $86.51 | +32.93% | 7 | Jun 3, 2022 | |
| ALC Alcon | Upgrades: Overweight | $86 → $92 | $88.79 | +3.62% | 4 | May 12, 2022 | |
| PLSE Pulse Biosciences | Maintains: Overweight | $14 → $12 | $11.41 | +5.17% | 2 | Apr 1, 2022 | |
| ANIK Anika Therapeutics | Downgrades: Equal-Weight | n/a | $26.03 | - | 2 | Mar 9, 2022 | |
| ESTA Establishment Labs Holdings | Maintains: Overweight | n/a | $42.75 | - | 2 | Nov 10, 2021 | |
| STE STERIS | Maintains: Overweight | n/a | $218.34 | - | 3 | Nov 4, 2021 | |
| GKOS Glaukos | Upgrades: Overweight | n/a | $118.98 | - | 3 | Nov 3, 2021 | |
| AVNS Avanos Medical | Downgrades: Equal-Weight | n/a | $19.50 | - | 1 | Aug 4, 2021 | |
| TFX Teleflex | Maintains: Overweight | n/a | $211.25 | - | 1 | Mar 23, 2020 | |
| STAA STAAR Surgical Company | Maintains: Overweight | n/a | $44.52 | - | 1 | Mar 23, 2020 | |
| DXCM DexCom | Maintains: Overweight | n/a | $112.49 | - | 2 | Mar 23, 2020 | |
| CUTR Cutera | Maintains: Overweight | n/a | $1.35 | - | 1 | Mar 23, 2020 | |
| BSX Boston Scientific | Maintains: Overweight | n/a | $76.55 | - | 1 | Mar 23, 2020 | |
| PODD Insulet | Maintains: Equal-Weight | n/a | $197.19 | - | 1 | Feb 22, 2018 |
Vericel
May 11, 2023
Maintains: Overweight
Price Target: $39 → $42
Current: $45.07
Upside: -6.81%
Align Technology
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $375
Current: $239.74
Upside: +56.42%
The Cooper Companies
Jun 3, 2022
Maintains: Overweight
Price Target: $125 → $115
Current: $86.51
Upside: +32.93%
Alcon
May 12, 2022
Upgrades: Overweight
Price Target: $86 → $92
Current: $88.79
Upside: +3.62%
Pulse Biosciences
Apr 1, 2022
Maintains: Overweight
Price Target: $14 → $12
Current: $11.41
Upside: +5.17%
Anika Therapeutics
Mar 9, 2022
Downgrades: Equal-Weight
Price Target: n/a
Current: $26.03
Upside: -
Establishment Labs Holdings
Nov 10, 2021
Maintains: Overweight
Price Target: n/a
Current: $42.75
Upside: -
STERIS
Nov 4, 2021
Maintains: Overweight
Price Target: n/a
Current: $218.34
Upside: -
Glaukos
Nov 3, 2021
Upgrades: Overweight
Price Target: n/a
Current: $118.98
Upside: -
Avanos Medical
Aug 4, 2021
Downgrades: Equal-Weight
Price Target: n/a
Current: $19.50
Upside: -
Teleflex
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $211.25
Upside: -
STAAR Surgical Company
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $44.52
Upside: -
DexCom
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $112.49
Upside: -
Cutera
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $1.35
Upside: -
Boston Scientific
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $76.55
Upside: -
Insulet
Feb 22, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $197.19
Upside: -